SCHEMBL8813629

SCHEMBL8813629

CC(C)(C)CCCCCCCCCCCCOC=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.31
PRKCA P17252 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039790 1.00 HRH3 (0.31) HRH3PRKCA
SCHEMBL3042472 1.00 HRH3 (0.31) HRH3PRKCA
SCHEMBL2384599 0.98 HRH3 (0.32) HRH3
SCHEMBL3041225 0.91 TDP1 (0.32) HRH3
SCHEMBL104131 0.80
SCHEMBL2285548 0.80 ALDH1A1 (0.32)
SCHEMBL2281979 0.80 ALDH1A1 (0.32)
SCHEMBL2278858 0.80 ALDH1A1 (0.32)
SCHEMBL2288073 0.80 ALDH1A1 (0.32)
SCHEMBL2283394 0.80 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed